Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction).
Authors
Goldberg, Robert J.Mooradd, Michael
Gurwitz, Jerry H.
Rogers, William J.
French, William J.
Barron, Hal V.
Gore, Joel M.
UMass Chan Affiliations
Department of Medicine, Division of Cardiovascular MedicineDepartment of Medicine, Division of Geriatric Medicine
Meyers Primary Care Institute
Document Type
Journal ArticlePublication Date
1998-08-01Keywords
Cross-Over StudiesFemale
Follow-Up Studies
Hospital Mortality
Humans
Male
Middle Aged
Myocardial Infarction
Plasminogen Activators
Registries
Retrospective Studies
Survival Rate
Time Factors
Tissue Plasminogen Activator
Treatment Outcome
United States
Health Services Research
Medicine and Health Sciences